Results 41 to 50 of about 1,915,304 (214)

Drug-eluting balloons in below the knee treatment. [PDF]

, 2016
The endovascular treatment of atherosclerotic disease of the infra-inguinal arteries has changed significantly since the introduction of drug-eluting balloon technology.
Van den Berg, Josua Cornelis
core   +2 more sources

Drug eluting hydrogels design, synthesis and evaluation [PDF]

, 2012
Hydrogels have successfully proved themselves useful for drug delivery applications and several delivery routes have been developed over the years. The particular interest in this work was to design, synthesise and evaluate in situ forming drug eluting ...
Ahrenstedt, Lage
core   +1 more source

Short Term Outcome of Drug Eluting Balloon for Percutaneous Coronary Intervention

Pakistan Armed Forces Medical Journal, 2023
Objective: To assess the short-term outcome of Drug Eluting Balloon (DEB) for Percutaneous Coronary Intervention (PCI).   Study Design: Analytical Cross-sectional study   Place and Duration of Study: Armed Forces Institute of Cardiology/National ...
Maida Anwar, Asif Nadeem, Fahad Ur Rehman, Sana Sarfraz, Iftikhar Ahmed, Naseem Azad, Muhamad Bilal Siddique, Javeria Kamran   +7 more
doaj   +1 more source

Sirolimus-Eluting Balloon vs Repeat Drug-Eluting Stent or Balloon Angioplasty for Coronary In-Stent Restenosis.

Journal of the American College of Cardiology
BACKGROUND Drug-eluting stents (DESs) are recommended treatment for coronary in-stent restenosis (ISR) but are not used in >20% of cases. OBJECTIVES The aim of the SELUTION4ISR (SELUTION SLR 014 In-stent Restenosis) trial was to assess the safety and ...
D. Cutlip, R. Mehran, Samin K. Sharma, G. Doros, Brian K. Jefferson, G. Stefanini, S. Dohad, A. Neylon, I. Ben-Dor, D. Patel, Bassem M. Chehab, A. Pradhan, R. Nerla, P. Vranckx, Marie-France Poulin, Allen Jeremias, E. Osborn, R. Waksman   +17 more
semanticscholar   +1 more source

Drug-Coated Balloon-Only Strategy for De Novo Coronary Artery Disease: A Meta-analysis of Randomized Clinical Trials

Cardiovascular Therapeutics, 2023
Backgrounds. Many clinical trials have demonstrated the value of drug-coated balloons (DCB) for in-stent restenosis. However, their role in de novo lesions is not well documented.
Wenyi Zhang, Mingduo Zhang, Jinfan Tian, Min Zhang, Yuan Zhou, Xiantao Song   +5 more
doaj   +1 more source

Zotarolimus-eluting stent fracture at initial implantation diagnosed with StentBoost

SAGE Open Medical Case Reports, 2016
Stent fracture is a rare complication of drug-eluting stent implantation with a reported rate of 0.84%–3.2% in various clinical studies with first-generation drug-eluting stents and 29% in autopsy studies.
Alev Arat Ozkan, Umit Yasar Sinan, Aziz T Gurmen   +2 more
doaj   +1 more source

The compounding effects of obesity on the development of Intimal Hyperplasia following vascular intervention : a histopathological analysis [PDF]

, 2009
Includes abstract.Includes bibliographical references (leaves 100-111).This study examines the histopathological response to injury following both balloon angioplasty and endovascular stenting in the Zucker rat, a model that allows interpretation of the ...
Black, Melanie Kim
core   +1 more source

Rab1A Promotes Hepatic Steatosis by Suppressing Mitophagy via the Raf‐1/ERK1/2/PINK1 Signaling Axis

Advanced Science, EarlyView.
Why does fat accumulate in the liver? Our study reveals Rab1A as the molecular switch that silences the cell's mitochondrial cleanup crew. Turning Rab1A off reactivates mitophagy, clears excess fat, and reverses fatty liver disease in mice—offering a promising new therapeutic target for MASLD, a growing global health challenge.
Li Zhang, Jianhua Li, Huilu Zhang, Qi Qin, Yichen Huang, Xiaofan Tian, Chao Sun, Binbin Li, Zhengxin Wang, Xin Zhang   +9 more
wiley   +1 more source

Outcome of drug‐eluting balloon angioplasty versus endarterectomy in common femoral artery occlusive disease

Journal of Vascular Surgery, 2019
Objective: Common femoral artery (CFA) occlusive disease remains a debatable site for endovascular therapy, and the outcome of drug‐eluting balloon (DEB) angioplasty in treating CFA occlusive disease is largely unknown.
Tzu-Ting Kuo, Po-Lin Chen, Chun-Yang Huang, Chiu-Yang Lee, Chun-Che Shih, I. Chen   +5 more
semanticscholar   +1 more source

Global Drug-eluting Balloon Catheters Market Report 2023-2034

, 2023
The global drug-eluting balloon catheters market size was US$711.7 million in 2023 and is expected to reach at US$2,387.3 million by 2034 with a CAGR of 11.81% during the forecast period 2024-2034.
Erevna Healthcare
core   +1 more source